4//SEC Filing
Goeltz II Robert C. 4
Accession 0001653881-25-000007
CIK 0001724521other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:07 PM ET
Size
4.7 KB
Accession
0001653881-25-000007
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-26$25.00/sh−5,000$125,000→ 87,138 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001653881
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:07 PM ET
- Size
- 4.7 KB